Status:
COMPLETED
Prenatal Hormonal Markers and Sleep Characteristics in Young Adults With Joint Hypermobility
Lead Sponsor:
Nigde Omer Halisdemir University
Conditions:
Joint Hypermobility
Healty Controls
Eligibility:
All Genders
18-35 years
Brief Summary
Joint hypermobility is a clinical condition characterized by joints having a range of motion beyond their normal limits. Hormonal factors are thought to play a role in the development of joint hypermo...
Detailed Description
Estrogen affects collagen metabolism and connective tissue structure, which can lead to increased ligament laxity at high levels. Increased estrogen and progesterone during pregnancy cause significant...
Eligibility Criteria
Inclusion
- Individuals aged 18-35
- Individuals who scored 5 out of 9 or higher on the Beighton score
- Control group: Those with a Beighton score of ≤ 4
Exclusion
- Individuals with any pathology related to the musculoskeletal system
- Individuals diagnosed with metabolic, neurological, or genetic diseases (tissue diseases such as Ehlers-Danlos syndrome and Marfan syndrome)
- Those with a history of surgery within the last 6 months
- Those who are pregnant or breastfeeding
Key Trial Info
Start Date :
August 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 17 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT07157930
Start Date
August 20 2025
End Date
December 17 2025
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nigde Omer Halisdemir University
Niğde, Turkey (Türkiye)